# Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease

> **NCT00892450** · NA · COMPLETED · sponsor: **US Department of Veterans Affairs** · enrollment: 12 (actual)

## Conditions studied

- Parkinson's Disease
- Overactive Bladder

## Interventions

- **DRUG:** Oxybutynin and darifenacin

## Key facts

- **NCT ID:** NCT00892450
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00892450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00892450, "Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00892450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*